SXTC: China SXT Pharmaceuticals Operating Margin

SXT China (SXTC) - corporate logo

China SXT Pharmaceuticals (SXTC) volatility is smoothed by the diversification of raw material imports, which minimizes logistical risks. Revenues are based on wholesale supplies of phytopharmaceuticals to Chinese state hospitals, while the cultural specifics of demand ensure stability. The operating margin helps filter out market noise, with the indicator currently at -630.60, indicating the real efficiency of the core business.

SXTC - SXT China Operating Profit Rate over the range 07/04/2022 - 11/20/2026

Analytical breakdowns for China SXT Pharmaceuticals (SXTC)

Fundamental valuation:SXT Pharmaceuticals
Brand item of SXT China

Operating margin is calculated as the ratio of operating profit to total revenue. This indicator measures the internal efficiency of the business, stripped of the influence of debt load and the tax regime. For China SXT Pharmaceuticals (SXTC), high profitability is maintained by minimizing logistics costs through a network of local raw material warehouses. Supply chain optimization directly increases the share of profit from core operations. Analyzing this curve allows an investor to promptly track the operating resilience of the issuer.

Competitor analysis for China SXT Pharmaceuticals

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.